Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIVAX: Influenza Vaccination in Autoimmune Diseases
NCT01065285Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2009
- Primary completion
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ARCT-2138, Pandemic influenza A (H1N1) vaccine in influenza, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2009; status: completed.
02
Drugs
ARCT-2138Pandemic influenza A (H1N1) vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01065285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065285.